FDA NDC Directory · JSON-LD · Markdown

Epoprostenol

NDC 68083-707 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Labeler / ManufacturerGland Pharma Limited
Marketing categoryAbbreviated NDA (generic) · App ANDA219237
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsEPOPROSTENOL (.5 mg/10mL)
Marketing started20251229
Package count1

External sources

Source: openFDA. Public-domain (CC0).